AD/PD 2025 Vienna

Striving for a Better Future for Everyone Affected by Neurodegenerative Diseases

At AYE Exocure, we have presented our Alzheimer’s research and innovative product at the globally esteemed AD/PD 2025 Congress in Vienna. Our three distinct poster presentations detail the scientific process we’ve undertaken to explore the preventive potential of our product against Alzheimer’s disease. Subjected to a comprehensive series of scientific tests, our product was first examined in cell cultures, followed by studies on animal models, and ultimately tested in clinical trials involving Alzheimer’s patients.

Our studies, rigorously evaluated by the congress's international scientific committee, have received approval for their preventive efficacy against Alzheimer’s. This innovative product, developed and produced in Turkey, has thus gained official recognition from the international scientific community. Our posters will be physically displayed at the congress, which will take place in Vienna from April 1-5, 2025.

This international achievement not only reinforces AYE Exocure's contributions to global health but also showcases Turkey's strength in health research. With our commitment to developing scientific solutions for challenging diseases like Alzheimer’s, we will continue to make strides in contributing to human health.